Investigation of the Metabolism and Pharmacokinetics of 20 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as a 3-hour Infusion and 40 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as an Oral Solution.

Trial Profile

Investigation of the Metabolism and Pharmacokinetics of 20 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as a 3-hour Infusion and 40 µg (Calculated as Free Base) [14C]BI 1744 CL Administered as an Oral Solution.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2014

At a glance

  • Drugs Olodaterol (Primary) ; Olodaterol (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacokinetics
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 28 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top